Literature DB >> 19788639

Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.

Boldtsetseg Tserenpuntsag1, Kenrad Nelson, Ouynbileg Lamjav, Wayne Triner, Perry Smith, Marilyn Kacica, Louise-Anne McNutt.   

Abstract

BACKGROUND: Mongolia has one of the highest rates of viral hepatitis infections worldwide yet risk factors have been largely unstudied. This sentinel study of hepatitis infection in Mongolia determined the prevalence of hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) among a sample of blood donors and identified demographic and behavioral factors associated with hepatitis infection. STUDY DESIGN AND METHODS: Data were collected by interview from 923 Ministry of Health Blood Center donors between August 2004 and February 2005. The exposure variables collected included donor demographics and health and behavioral risk factors. Bivariate and multivariate analyses assessed the prevalence ratio of hepatitis infection for each exposure.
RESULTS: Of 923 donors, 72 tested positive for HBsAg (7.8%; 95% confidence interval [CI], 6.1%-9.7%), 89 donors tested positive for anti-HCV (9.6%; 95% CI, 7.8%-11.5%), and six (0.6%) tested positive for both HBsAg and anti-HCV. Prevalence of HBsAg was highest among donors 18 to 19 years and anti-HCV tended to be most prevalent among those more than 40 years of age. Both pregnancy and alcohol use were associated with seroprevalent anti-HCV.
CONCLUSION: This sentinel study of hepatitis prevalence among Mongolian blood donors sheds considerable light on the epidemiology of hepatitis virus infection as well as the sociodemographic and behavioral risk factors associated with infection. Young age (HBsAg) and pregnancy (anti-HCV) were significant risk factors for hepatitis virus infection, indicating that improvements in education, vaccination rates, and general infection control procedures in health care institutions may reduce behavioral and nosocomial transmission.

Entities:  

Mesh:

Year:  2009        PMID: 19788639     DOI: 10.1111/j.1537-2995.2009.02387.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Hepatitis B infection in the Asian and Latino communities of Alameda County, California.

Authors:  Kevin Hur; Myo Wong; Joshua Lee; Joyce Lee; Hee-Soon Juon
Journal:  J Community Health       Date:  2012-10

2.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

3.  Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa.

Authors:  Gary M Clifford; Tim Waterboer; Bolormaa Dondog; You Lin Qiao; Dimitri Kordzaia; Doudja Hammouda; Namory Keita; Nahid Khodakarami; Syed Ahsan Raza; Ang Tshering Sherpa; Witold Zatonski; Michael Pawlita; Martyn Plummer; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2017-02-02       Impact factor: 2.965

Review 4.  Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors.

Authors:  Elrashdy M Redwan; Abdullah A Aljadawi; Vladimir N Uversky
Journal:  Biology (Basel)       Date:  2022-07-21

5.  Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.

Authors:  Belete Biadgo; Elias Shiferaw; Berhanu Woldu; Kefyalew Addis Alene; Mulugeta Melku
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.